CompletedNot Applicable

Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

Japan387 participantsStarted 2009-10

Plain-language summary

This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® long-term treatment of growth hormone deficiency in adults.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Severe adult growth hormone deficiency Exclusion Criteria: * Known or suspected allergy to study product(s) or related products * Previous participation in the study * Diabetes Mellitus * Presence of malignant tumor(s) * Pregnant or likely to get pregnant

What they're measuring

Number and type of suspected serious adverse drug reactions (SADRs) during the study period

Timeframe: after 5 years

Trial details

NCT IDNCT01109017

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2014-12

View on ClinicalTrials.gov More Growth Hormone Disorder trials